It has been observed that the frequencies of FLT3-TKD, FLT3-ITD, and NPM1 mutations were higher in Iranian CN-AML patients compared with AML subjects with cytogenetic anomalies. This evidence concerns the gene NPM1 and acute myeloid leukemia.